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Background: Immunoglobulin A nephropathy (IgAN) and thin glomerular base-
ment membrane nephropathy (TBMN) are the most common causes of persistent
hematuria during childhood. The objective of this study is to determine the
difference in clinical features and laboratory ﬁndings between pediatric patients
with IgA deposited TBMN and IgAN alone.
Methods: Between January 2000 and March 2009, 95 children were diagnosed
with IgAN by renal biopsy. Clinical features and laboratory ﬁndings of patients with
isolated IgAN and with IgAN plus TBMN were compared; the children diagnosed
with IgAN were compared to 127 children who had been diagnosed with TBMN
alone during the same period.
Results: There were 71 (74.7%) of a total 95 patients that were diagnosed with
isolated IgAN (Group1); in 24 (25.3%) of the 95 patients IgAN was combined with
TBMN (Group 2). There was marked difference in the gender distribution between
Group 2 and isolated TBMN patients. The degree of proteinuria and pathologic severity
was higher in Group 1 compared with Group 2. Gross hematuria was present in both
groups. There were no distinguishing features in the other laboratory parameters.
Conclusion: Patients with both IgAN and TBMN seem to have similar clinical features
to patients with isolated IgAN; however, the latter tend to have better pathologic and
laboratory ﬁndings, compared to the patients with IgAN alone.
& 2013. The Korean Society of Nephrology. Published by Elsevier. This is an open
access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Thin glomerular basement membrane nephropathy (TBMN)
and IgA nephropathy (IgAN) are the most common causes
of primary glomerular disease with persistent hematuria in
children [1,2]. Since January 1998 in Korea, all school children
undergo a mandatory urine screening test for the earlyn Society of Nephrology. Publi
c-nd/4.0/).
rics, Kyungpook National
-ro, Jung-gu, Daegu 700-detection of chronic kidney disease. Park et al. [3] reported
that more than 72.5% of children showing isolated microscopic
hematuria in mass school urine screening test were diagnosed
with IgAN or TBMN.
Although these two diseases are similar in their clinical
features, patients with IgAN tend to have gross hematuria and
proteinuria; it is also known that renal impairment and renal
failure can occur during the course of the IgAN [4,5].
Some studies have reported patients with TBMN and IgAN,
coincidently. These patients showed heavy proteinuria and
progression of renal impairment that have similar character-
istics to the patient with a prognosis of IgAN alone [6].shed by Elsevier. This is an open access article under the CC BY-NC-ND
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clinical manifestations between IgAN with TBMN patients and
isolated IgAN or TBMN patients during childhood.Methods
On a retrospective basis, we performed a cross-sectional
study. We reviewed the medical records of 222 patients who
had been diagnosed with IgAN or TBMN from January 2000
to March 2009 at Kyungpook National University Hospital.
We divided 95 patients diagnosed with having IgAN into two
groups: patients with IgAN alone were classiﬁed into Group
1 and patients with thinning of glomerular basement membrane
on electron microscopy, as well as mesangial IgA deposition,
were classiﬁed into Group 2. We compared the clinical manifes-
tations between these two groups. In addition, we compared
these two groups with isolated TBMN patients, who had been
diagnosed at our institution during the same period (Group 3).
The diagnosis of TBMN was based on the criteria proposed
by Yoshikawa et al. [7] in 1984. Based on this criterion, biopsy
of the kidney reveals thinning of the glomerular basement
membrane at o250 nm on electron microscopy with normal
ﬁndings on light microscopy and on immunoﬂuorescence
microscopy. The thickness of the glomerular basement mem-
brane was measured as at least more than ﬁve capillary loops
and is regarded as diagnostic when 450% of total visible
glomeruli are affected. IgAN was classiﬁed based on criteria of
the Haas' classiﬁcation [8].
We compared male to female ratio and average age of each
group; in addition, we investigated clinical features, laboratory
ﬁndings, existence of gross hematuria, degree of proteinuria,
and blood pressure at the time of renal biopsy. Because of the
cross-sectional design, it was not possible to ﬁnd results of the
spot urine protein to creatinine ratio in every patient, so we
used the results of a dipstick test using ﬁrst morning urine.Table 1. Clinical features and laboratory ﬁndings of the patients
Findings IgAN (Group 1)
Demographic characteristics
Number 71
Sex (M:F) 49:22
Age at biopsy (y) 11.072.95
Clinical parameters
Gross hematuria 71 (1 0 0)
Proteinuria (o100 mg/dL:4100 mg/dL) 38 (53.5):33 (46.5)
SBP (mmHg) 115.2711.40
DBP (mmHg) 63.779.26
Pathologic ﬁndings
Hass Class I–II:III–V 36 (50.7):35 (49.3)
Thickness of GBM (nm)
Laboratory ﬁndings
Hemoglobin (g/dL) 12.771.30
BUN (mg/dL) 11.973.54
Creatinine (mg/dL) 0.770.67
Sodium (mmol/L) 138.673.05
Potassium (g/dL) 4.170.35
Protein (g/dL) 6.870.82
Albumin (g/dL) 4.170.56
Calcium (mg/dL) 9.370.66
Phosphate (mg/dL) 4.670.68
n P is the statistical value between Group 1 and Group 2.
Data are presented as mean7SD or n (%).
BUN, blood urea nitrogen; DBP, diastolic blood pressure; F, female; GBM, glomer
NS, nonspeciﬁc; SBP, systolic blood pressure; TBMN, thin glomerular basemenStatistical analysis was performed using SPSS version 12.0
(SPSS Inc., Chicago, IL, USA) and the difference of frequency was
analyzed by Chi-square test and analysis of variance (ANOVA). A P
valueo0.05 was considered to be statistically signiﬁcant.Results
Of the 222 children enrolled, there were 95 IgAN patients,
and 127 TBMN patients. Of 95 children with IgAN, 71 children
(Group 1, 74.7%) were diagnosed with isolated IgAN and in 24
(Group 2, 25.3%) IgAN was accompanied by TBMN. The mean
age of Groups 1 and 2 were 11.072.95 (range, 5.3–16.3) years
and 10.973.04 (range, 6.9–16.4) years, respectively. Male to
female ratio was 7:3 in both groups. In Group 3, the mean age
was 7.972.84 (range 0.5–14.1) years and the male to female
ratio was 5:5; the results of Group 2 resembled Group 1 in age
and male predominance (Table 1).
Although no patient had gross hematuria in Group 3,
all children in Groups 1 and 2 had an accompanying history
of gross hematuria.
The average thickness of the glomerular basement mem-
brane in Group 2 was 205.8731.1 nm. It was thicker than that
of Group 3 (183.8735.7 nm).
There were 33 (46.5%) children with proteinuria of 4100mg/
dL in Group 1 and ﬁve (20.8%) in Group 2; thus, the patients with
isolated IgAN showed more severe proteinuria (P¼0.04).
Mean systolic blood pressure of Group 1, Group 2, and Group
3 was 115.2711.40 mmHg, 113711.79 mmHg, and 109.97
10.0 mmHg, respectively. Mean diastolic blood pressure of
Group 1, Group 2, and Group 3 was 63.779.26 mmHg, 65.37
5.95 mmHg, and 59.677.85 mmHg, respectively (Po0.01).
Histologic types of each group by Haas′ classiﬁcation were
as follow: Class I was the most common type (47%), and
Class III accounted for 37% in Group 1 (Fig. 1). In addition, in
Group 2, Class I was the most common histologic type (63%)IgAN+TBMN (Group 2) TBMN (Group 3) Pn
24 127
18:6 59:68
10.973.04 7.972.84
24 (1 0 0) 0% 0.92
19 (79.2):5 (20.8) 0.04
113711.79 109.9710.0 o0.01
65.375.95 59.677.85 o0.01
17 (70.8):7 (29.2) 0.08
205.8731.1 183.8735.7 0.04
12.871.10 12.470.99 NS
12.576.32 10.372.71 NS
0.770.32 0.670.12 NS
138.774.93 138.572.50 NS
4.1670.32 4.270.33 NS
7.170.35 7.170.48 NS
4.370.29 4.470.22 NS
9.470.43 9.470.41 NS
4.770.73 4.570.63 NS
ular basement membrane; IgAN, immunoglobulin A nephropathy; M, male;
t membrane nephropathy.
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Figure 1. The proportion of Haas′ class of the patients. Group 1,
immunoglobulin A nephropathy; Group 2, immunoglobulin A nephro-
pathy with thin glomerular basement membrane nephropathy.
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of children with Class I–II:Class III–V by Haas′ classiﬁcation
of Group 1 was 35 (49.3%):36 (50.7%) and of Group 2 was 17
(71.9%):7 (29.1%); however, there was no statistically signiﬁ-
cant difference (P¼0.08).
There were no signiﬁcant differences in laboratory ﬁndings
among these groups (Table 1).Discussion
Double glomerulopathy that combines two kinds of glo-
merulonephritis has been reported in several studies and the
pathogenesis is still controversial in terms of whether they
occur at same time by chance or are a different disease entity
to the one disease belonging to another. The frequency of
double glomerulopathy was reported to be 6.7% by Bertani
et al. [9], 0.5% by Monga et al. [10] and 3.1% by Cheong et al.
[11]. In particular, TBMN is known to be commonly accom-
panied with IgAN [6,12].
Shigematsu et al. [13] reported that focal or diffuse thinning
of the glomerular basement membrane is observed in the IgAN
patient; since that time, several studies have shown cases of
IgAN with TBMN. The ﬁrst case of TBMN with IgAN was
reported by Monga et al. [14] and ﬁrst pediatric case was
reported by Yoshida et al. [15].
The reason for TBMN being frequently accompanied by other
glomerulonephiritis is still not known. Lanteri et al. [16] suspected
that the thin glomerular basement membrane is more vulnerable
to being injured and both TBMN and IgAN are common types of
glomerulonephritis, so they may occur accidentally.
In our study, the frequency of the coexistence of TBMN in
IgAN patients was 25.3% (24/95), which is less than that found
by Chi et al. [17] (37.4%; 19/51). Although several studies were
published that the frequency was 1.8% (2/110; Lanteri et al.
[16]), 18.5% (10/54; Cosio et al. [12]), they reported frequency
of combined IgAN among TBMN patients. Thus, an exact
comparison of frequency with our study is not valid, if we
analyze the data based on the TBMN patient, the prevalence of
the coexistence of the diseases is about 15.8% (24/151) in
our study.
We recognized that patients with both IgAN and TBMN
are more common in males and all have a history of gross
hematuria; thus, the clinical features are very similar to isolated
IgAN patient. In addition, Trinn and Nagy [18] reported thatpatients with both diseases demonstrate a high incidence of
gross hematuria.
Research into the prognosis of this condition (IgAN with
TBMN) is insufﬁcient, although the majority of investigators
suggest that most patients follow the clinical manifestation
and prognosis of isolated IgAN. In general, the clinical features
of IgAN are comparable with TBMN, but the occurrence of
gross hematuria or proteinuria is more predominant in IgAN.
In addition, it is known that about 20–30% of patients with
IgAN progress to end stage renal disease within 20 years [19].
Norby and Cosio [21] reported that patients with IgAN and
TBMN have a worse prognosis compared with isolated TBMN
and Berthoux et al. [20] described their prognosis as similar
to isolated IgAN. Lanteri et al. [16] revealed that more severe
microscopic hematuria and proteinuria, and a higher blood
pressure were found in patients with TBMN and IgAN to meet
the clinical manifestations of IgAN, although their serum
creatinine and creatinine clearance were maintained. Accord-
ingly, the authors suggest that the prognosis for patients
with both diseases is related to the degree of mesangial IgA
deposition, similar to IgAN.
The ratio of patients with proteinuria 4100 mg/dL was
5/24 (20.8%) in IgAN with TBMN group, which is signiﬁcantly
lower than 33/71 (46.5%) in the isolated IgAN group.
Blood pressure was highest in the IgAN group, followed by
IgAN with TBMN and TBMN. Although statistical signiﬁcance
was shown, there were no hypertensive patients in Groups
2 or 3, so it is difﬁcult to deduce clinical implication. However,
it is evident that patients with IgAN show much higher blood
pressure than others.
Although there was no statistical signiﬁcance, the ratio of
patients with higher than Haas Class III on histology was lower in
Group 2 (7/24; 29.2%) than in Group 1 (35/71; 49.3%). Unfortu-
nately, most of the studies are based on comparisonwith isolated
TBMN patients; the difference in histological ﬁndings and the
degree of proteinuria with isolated IgAN patients was unfeasible.
However, our results show that proteinuria and histological
ﬁndings in patients with both IgAN and TBMN are milder than
those with isolated IgAN. It is hard to identify the reason for
IgAN with TBMN showing less proteinuria than the IgAN. We
can speculate that TBMN serves a protective role against IgAN.
In order to identify the exact cause, long-term follow-up and
additional renal biopsy are needed.
Interestingly, Norby and Cosio [21] reported that when the
TBMN accompanied IgAN, the clinical features and prognosis
are not worse than for isolated IgAN, although in the case
of other glomerulonephritis combined with TBMN showed a
more severe outcome. Therefore, it is possible that the thin-
ning of glomerular basement membrane may be associated
with a better prognosis for IgAN. Considering that the majority
of studies have investigated the characteristics and prognosis
based upon TBMN patients, our study is worthwhile from a
different point of view as it is based upon that of IgAN patients.
The limitations of our study include the fact that the
indication of renal biopsy is diverse so that selection bias can
occur. Also the long-term clinical features are not considered.
Further research about the long-term clinical course and clinical
characteristics are needed for both groups of patients.Conﬂicts of interest
None to declare.
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